ANI Pharmaceuticals SVP Thomas Rowland Sells 459 Shares at $79.21

This SEC Form 4 filing reports that Thomas Rowland, SVP and Head of Established Brands at ANI Pharmaceuticals Inc, sold 459 shares of common stock on May 12, 2026, at a price of $79.21 per share. Following this transaction, Rowland now holds 38,271 shares directly. The filing was signed on May 13, 2026, by attorney-in-fact Meredith W. Cook on behalf of Rowland. The transaction represents a routine insider sale by a senior executive of the pharmaceutical company. Rowland maintains a significant ownership position in ANI Pharmaceuticals with over 38,000 shares following the sale. The filing provides standard disclosure of insider transactions as required by SEC regulations for company officers and directors.